Imagine medicines that can repair a gene, reprogram a cell, or regenerate tissue.
These are not dreams — they are advanced therapy medicinal products (ATMPs): gene, cell, and tissue-based therapies that are redefining modern medicine.

But innovation without regulation is a risk, and regulation without boldness is a brake. This international conference is designed as a laboratory of ideas, a strategic crossroads, where law, science, industry, and society come together to shape the future.

For two days, legal scholars, researchers, industry leaders, regulators, sociologists, and frontline professionals will confront their perspectives. Europe, the United States, health agencies, pharmaceutical companies, patients — an unfiltered dialogue on the major disruptions ahead.

This conference is designed as an accelerator of ideas, a prototyping space for legal innovation, ready to take on the challenges posed by ATMPs:

➡️ Legal and regulatory frameworks
➡️ Emerging responsibilities
➡️ Intellectual property and economic models
➡️ Informed consent, equitable access, and social justice